Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
MDK-703 / Medikine
ORCHID-1, NCT05716295: A Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid Tumors	Terminated	1/2	26	US	MDK-703, Checkpoint Inhibitor, Immune	Medikine, Inc.	Advanced or Metastatic Solid Tumors	04/24	04/24
NCT05366634: A Single Ascending Dose Study to Evaluate MDK-703 in Healthy Adult Volunteers	Completed	1	26	RoW	MDK-703 or Placebo	Medikine, Inc., Medikine Australia Pty Ltd.	Healthy Volunteers	12/22	12/22